Back
NewAmsterdam Pharma Co NV 10K Form
Buy
82
NAMS
NewAmsterdam Pharma Co NV
Last Price:
25.55
Seasonality Move:
50.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NAMS News And Ratings
See the #1 stock for the next 7 days that we like better than NAMS
NAMS Financial Statistics
Sales & Book Value
Annual Sales: | $14.09M |
---|---|
Cash Flow: | $-12.58M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.11 |
Price / Book: | 6.39 |
Profitability
EPS (TTM): | -2.25000 |
---|---|
Net Income (TTM): | $-198.92M |
Gross Margin: | -- |
Return on Equity: | -51.66% |
Return on Assets: | -46.22% |
NewAmsterdam Pharma Co NV Earnings Forecast
Key NewAmsterdam Pharma Co NV Financial Ratios
- The Research & Development expenses have been 1,131.47% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of NAMS is -1,255.76% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 0 years.
NewAmsterdam Pharma Co NV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | NAMS |
Website: | newamsterdampharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 10.61 |
Quick Ratio: | 10.37 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
NAMS Technical Analysis vs Fundamental Analysis
Buy
82
NewAmsterdam Pharma Co NV (NAMS)
is a Buy
Is NewAmsterdam Pharma Co NV a Buy or a Sell?
-
NewAmsterdam Pharma Co NV stock is rated a Buy
The current NewAmsterdam Pharma Co NV [NAMS] share price is $26.19. The Score for NAMS is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.